Affinity chromatography market seen topping $5 billion by 2030

The Business Research Company says the affinity chromatography market is expanding on stronger biopharmaceutical manufacturing and research demand, with revenue projected to rise from $3.93 billion in 2026 to $5.07 billion by 2030. North America held the largest regional share in 2025, while growing monoclonal antibody demand and downstream processing needs are shaping the outlook.

Why it matters: - Affinity chromatography is a core purification step for proteins, antibodies and other biomolecules used in biopharmaceutical production. - Rising demand for biologics and personalized medicine is increasing the need for high-purity separation tools. - The market’s projected growth signals continued investment in downstream processing technologies.

What happened: - The Business Research Company released its Affinity Chromatography Market Analysis Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will grow from $3.68 billion in 2025 to $3.93 billion in 2026. - The report projects the market will reach $5.07 billion by 2030. - North America held the largest share of the affinity chromatography market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available. - The full market report is also available.

The details: - The market is forecast to grow at a 6.8% compound annual growth rate in 2026. - The report projects a 6.5% CAGR through 2030. - The company ties near-term growth to biopharmaceutical manufacturing, research on recombinant proteins, wider use of affinity-based separation methods and stronger support for academic and research institutions. - Longer-term growth is expected from demand for monoclonal antibodies, more biologics investment, personalized medicine research and interest in single-use chromatography technologies. - Affinity chromatography works by using a complementary binding partner attached to a solid support to isolate specific target molecules from complex mixtures. - The technique is used to purify proteins, antibodies and other biomolecules. - Sartorius reported that global biopharmaceutical sales rose about 9% to $458 billion in 2024. - Sartorius also said biopharmaceuticals made up 41% of the overall pharmaceutical market in 2024, up from 40% in 2023.

Between the lines: - The report points to a market shaped less by broad lab demand and more by industrial-scale biologics production. - The emphasis on monoclonal antibodies and downstream processing suggests buyers are prioritizing purification efficiency and product purity. - North America’s lead likely reflects the region’s established biopharma base and research ecosystem, while the regional breakdown suggests growth opportunities remain global.

What's next: - The market is expected to keep expanding as biologics pipelines grow and more manufacturers adopt advanced purification workflows. - The report highlights updated visuals, market attractiveness scoring, TAM analysis, company scoring matrices and forecasting dashboards for strategy planning. - The Business Research Company is promoting direct access to its report data and related market materials through its sales team and website. - Follow the company on LinkedIn for updates.